Recent progress in generation of human surrogate β cells.

Area of Science:

• * Regenerative Medicine
• * Stem Cell Biology
• * Diabetes Research

Background:

• * Current limitations in generating functional human beta cells for transplantation.
• * The need for scalable and safe sources of insulin-producing cells.
• * Understanding beta cell biology and developmental pathways is crucial.

Purpose of the Study:

• * To review recent advancements in developing human surrogate beta cells.
• * To identify key challenges hindering clinical translation.
• * To highlight strategies for overcoming these obstacles.

Main Methods:

• * Analysis of in vitro differentiation and reprogramming techniques.
• * Evaluation of stem cell-based approaches for beta cell generation.
• * Review of studies on donor beta cell expansion and redifferentiation.

Main Results:

• * Successful redifferentiation of dedifferentiated donor beta cells via Notch pathway inhibition.
• * Progress in isolating and expanding intermediate-stage cells from pluripotent stem cells.
• * Demonstrated role of mesenchyme in pancreas progenitor expansion.
• * Identified incomplete Polycomb-mediated repression as a cause of immature in vitro beta cell phenotype.
• * Induced pluripotent stem cells from beta cells show enhanced differentiation capacity.
• * In vivo reprogramming of non-beta cells into beta-like cells achieved in mice.

Conclusions:

• * New strategies are emerging based on insights into donor cell expansion, stem cell differentiation, and cell reprogramming.
• * Overcoming current roadblocks will facilitate the generation of abundant human surrogate beta cells.
• * These advancements bring the clinical application of beta cell replacement therapies closer.